ARCHIVES

Congressional committee investigates former NCI Director Richard Klausner’s role in $40 million Harvard contract; NIH begins internal review. Klausner: investigation casts “strange innuendoes.” Text of committee’s letter.

This article is from The Cancer Letter archive.

Vol. 29 No. 42 | November 14, 2003

Download PDF Visit The Full Archive

Related Articles

Tamoxifen Offers Long-Term Benefits For Prevention

March 30, 2007

Congress Agrees On $1.989 Bil. FY92 NCI Budget, But Most Of Increase Not Available Till 1993

November 8, 1991

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

June 25, 2010

Trial Needed Of PSA To Determine Patients To Test, Chabner Says

March 5, 1993

Harold Varmus Nominated For NIH Director; Selection Wins Support of Biomedical Community

August 13, 1993

In Brief: Magnuson Delays Action On Apparitions Bill; No Vote See Now Until September

July 28, 1978